Company Search:
Advanced Search
Sponsored Links
Coherus Biosciences Inc Company Snapshot
Coherus Biosciences Inc operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Coherus Biosciences Inc with three other companies in this sector in the United States: YBCC Inc (2017 sales of $2.10 million ), CTD Holdings Inc ($1.24 million ), and Nutralife Biosciences Inc ($1.79 million ).

Sales Analysis. Sales fell dramatically in 2017: Coherus Biosciences Inc reported sales of $1.56 million for the year ending December of 2017. This represents a sharp decrease of 99.2% versus 2016, when the company's sales were $190.11 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Coherus Biosciences Inc
  Stock Performance Chart for Coherus Biosciences Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): 18.55
(Figures in U.S. Dollars)
1 Week -11.6%   13 Weeks -8.2%  
4 Weeks -3.5%   52 Weeks 39.2%  
Coherus Biosciences Inc Key Data:
  Ticker: CHRS Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2017 Sales 1,556,000
(Year Ending Jan 2018).
Employees: 232
  Currency: U.S. Dollars Market Cap: 1,291,583,595
  Fiscal Yr Ends: December Shares Outstanding: 69,627,148
  Share Type: Common Closely Held Shares: 5,494,526
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.